Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,528 public trials 2,839 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

NCT00724334

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 840103 La Jolla, California, United States
  • Investigational Site Number 840102 Stanford, California, United States
  • Investigational Site Number 840105 Boston, Massachusetts, United States
  • Investigational Site Number 840106 Ann Arbor, Michigan, United States
View Trial Details
Completed

Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly

NCT01692366

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Investigational Site Number 392010 Akita, Japan
  • Investigational Site Number 392002 Bunkyō City, Japan
  • Investigational Site Number 392006 Bunkyō City, Japan
  • Investigational Site Number 392004 Sendai, Japan
View Trial Details
Completed

Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

NCT03011034

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Washington University School Of Medicine St Louis, Missouri, United States
  • University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • ZNA Stuivenberg Antwerp, Belgium
View all 21 locations
View Trial Details
Completed

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

NCT02636855

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute (Stanford University) Stanford, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute, 701 NW 13th Street Boca Raton, Florida, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 36 locations
View Trial Details
Completed

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT02396134

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT04126681

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Gongdong, China
  • Nanfang hospital of southern medical university Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View all 22 locations
View Trial Details

Related conditions